mg dL

Related by string. mg dl * MGS . MGD . Mg . mgd . MGs . mgs . MG : Yard Freestyle =-#.# mg dL . mg tablets . mg mL . mg ml . kilogram mg kg . mg kg dose . MG Rover / DL . DLS . dl . DLD . DLs . Dl . ding ling : DL stint . ng dL . ng dl . DL Calarco Funeral Home . -DL Albert Haynesworth . DL Albert Haynesworth . DL Myron Pryor * -#.# mg dL [002] . -#.# mg dL [001] . -# mg dL . #-# mg dl . mg dL triglycerides . #-# mg dL *

Related by context. All words. (Click for frequent words.) 83 mg dl 73 ng mL 73 mmHg 73 mmol L 72 g dL 72 mm Hg 70 ng dL 70 mmol l 69 #mg/dL [001] 69 nmol L 69 HbA1c 68 ng ml 68 HbA1c levels 67 #mg/dl 67 HbA 1c 67 #mg/dL [002] 67 fasting blood glucose 67 mg d 66 mL/min/#.# m 2 66 pg mL 65 mEq L 65 A1C 65 g dl 65 -#.# mg dL [002] 65 hemoglobin A1c HbA1c 65 baseline HbA1c 65 sUA 65 fasting glucose 65 serum phosphorus 64 systolic blood pressure 64 LDL C 64 fasting plasma glucose 64 systolic BP 64 creatinine clearance 63 eGFR 63 per deciliter mg 63 mIU L 63 serum potassium 62 fasting plasma glucose FPG 62 serum uric acid 62 creatinine ratio 62 pg ml 62 #.#mmol L [002] 62 Hb A1C 62 cholesterol LDL C 62 #mmHg [002] 62 glycated hemoglobin 61 mm Hg systolic 61 nanograms per 61 lispro 61 HbA 1c levels 61 glycated hemoglobin levels 61 mmHg diastolic 61 plasma glucose levels 61 #.#mg/dL 61 transferrin saturation 61 highest tertile 61 HbA1C 61 urinary albumin 61 CrCl 61 A1C levels 61 impaired fasting glucose 61 OGTT 61 pmol L 61 A1c levels 61 fasting triglyceride levels 61 copies mL 61 creatinine 61 umol L 61 antihypertensive medications 61 mmol L. 61 serum creatinine levels 61 mmHg systolic 60 #.#mmol l [002] 60 LDL cholesterol levels 60 #.#ng/ml 60 mmol liter 60 μmol L 60 baseline serum creatinine 60 hemoglobin A1c 60 mU L 60 kg/m2 60 A1c 60 mL min 60 statistical significance p 60 alanine aminotransferase 60 x ULN 60 glycosylated hemoglobin HbA1c 60 hsCRP levels 60 hemoglobin A1c levels 59 alanine aminotransferase ALT 59 NPH insulin 59 μg L 59 mmol 59 elevated LDL cholesterol 59 insulin detemir 59 triglyceride levels 59 glycated hemoglobin HbA1c 59 diastolic BP 59 #.#mmol L [001] 59 nonfasting triglyceride levels 59 #mmHg [001] 59 serum testosterone 59 glycosylated hemoglobin 59 serum sodium 59 p = #.# [002] 59 mIU ml 59 milligrams deciliter 59 virologic failure 59 mg QD 59 serum urate 59 #mg/day [001] 59 hemoglobin A1C 59 hemoglobin concentrations 59 μg dL 59 placebo p 59 aspartate aminotransferase AST 58 normotensive 58 cardiovascular mortality 58 Fasting glucose 58 MADRS score 58 hydroxyvitamin D levels 58 nmol L. 58 IU mL 58 LVEF 58 CDAI score 58 Cmax 58 mean baseline HbA1c 58 LDL 58 serum calcium 58 recurrent VTE 58 nondiabetic patients 58 CK MB 58 diastolic blood pressure 58 mg 58 proteinuria 58 insulin glargine 58 FEV1 58 moderate renal impairment 58 total cholesterol LDL 58 serum IGF 58 nmol l 58 hs CRP 58 ng dl 57 LDL cholesterol 57 Fasting blood glucose 57 mcg kg 57 severe renal impairment 57 microalbuminuria 57 systolic 57 nmol liter 57 mm Hg diastolic 57 nanomoles per 57 baseline A1C 57 PSA nadir 57 diastolic blood pressures 57 tHcy 57 advanced adenoma 57 statin monotherapy 57 subclinical hypothyroidism 57 mg dose 57 μg 57 serum phosphate 57 ml kg 57 Triglyceride levels 57 mg TID 57 prehypertensive 57 HOMA IR 57 apnea hypopnea index 57 fasting glucose levels 57 #.#/#.# mmHg [001] 57 BENICAR HCT 57 copies ml 57 serum concentrations 57 definite stent thrombosis 57 log# copies mL 57 serum creatinine 57 #/#mmHg 57 serum phosphate levels 57 Hb A1c 57 nmol 57 lowest tertile 57 mg BID 57 baseline Hb 57 glomerular filtration rate 57 placebo p = 57 placebo 57 mcg 57 dapagliflozin plus 57 mcg dL 56 Hemoglobin A1C 56 mL/min/#.# m2 56 fasting insulin 56 oral glucose tolerance 56 statin therapy 56 serum glucose 56 advanced adenomas 56 p = #.# [004] 56 unfractionated heparin 56 serum urate levels 56 mIU mL 56 plasma glucose 56 mcg mL 56 vertebral fracture 56 % CI #.#-#.# [006] 56 adjunctive placebo 56 MMSE scores 56 HbA1C levels 56 HBeAg seroconversion 56 lopinavir r arm 56 triglycerides ≥ 56 HDL C 56 serum triglycerides 56 urine albumin 56 NT proBNP 56 peginterferon alfa 2a 56 aminotransferases 56 #ng/ml 56 hemoglobin concentration 56 systolic pressure 56 achieved ACR# 56 % CI #.#-#.# [003] 56 undetectable HCV RNA 56 cells uL 56 serum vitamin D 56 primary hypercholesterolemia 56 median PFS 56 n = 56 nonfatal MI 56 serum phosphorus levels 56 lumbar spine BMD 56 undetectable HBV DNA 56 Hb levels 56 tirofiban 56 elevated creatinine 56 aspartate aminotransferase 56 nondiabetics 56 binary restenosis 56 nondiabetic 55 DAS# [002] 55 urinary albumin excretion 55 per deciliter 55 ACR# response 55 creatinine levels 55 albumin excretion 55 hypogonadal 55 diastolic pressure 55 REYATAZ r arm 55 μg mL 55 serum selenium 55 lactate dehydrogenase LDH 55 benazepril 55 albuminuria 55 oxycodone CR 55 Median survival 55 pioglitazone 55 serum bilirubin 55 QTcF 55 valsartan 55 confidence interval #.#-#.# 55 % Confidence Interval 55 mg kg 55 Hb 55 mU liter 55 plasma urate 55 μmol l 55 p = 55 systemic embolism 55 -#.# mg dL [001] 55 homocysteine concentrations 55 statistically significant p 55 elevated ALT 55 thyrotropin levels 55 mean serum phosphorus 55 specific antigen PSA 55 neutrophil counts 55 #mg/day [002] 55 postprandial glucose PPG 55 PREZISTA r arm 55 undetectable viral load 55 confidence interval CI 55 biochemical relapse 55 P = .# 55 virologic response 55 milligrams mg 55 milligrams 55 plasma folate 55 IIIa inhibitors 55 pCR 55 nonsignificant 55 serum magnesium 55 cells/mm3 55 milliliter ng ml 55 transaminases 55 μg kg 55 urinary N telopeptide 55 troponin T 55 elevated CRP 55 plasma HCV RNA 55 low density lipoprotein 54 hip BMD 54 atorvastatin #mg 54 C reactive protein 54 HbA 1C 54 PASI scores 54 54 log# 54 glulisine 54 intact parathyroid hormone 54 glycemia 54 serum potassium levels 54 glimepiride 54 CI -#.# 54 LANTUS R 54 BENICAR 54 infliximab monotherapy 54 μg d 54 index BMI 54 Hazard Ratio HR 54 concomitant medications 54 mcg BID 54 severe hypoglycemic 54 beta blocker therapy 54 evaluable subjects 54 fasting serum 54 mg kg Hematide 54 titrated 54 rizatriptan 54 hypokalemia 54 asymptomatic carotid stenosis 54 oral antidiabetic medication 54 lipid lowering therapy 54 triacylglycerol concentrations 54 postprandial glucose 54 ug kg 54 NCEP ATP III 54 arterial thromboembolic events 54 anemia hemoglobin 54 plasma uric acid 54 prehypertension 54 hypoglycemia 54 antihypertensive therapy 54 Apidra ® 54 urinary oxalate 54 homocysteine levels 54 nonfasting 54 sUA levels 54 mg/m2 dose 54 μg liter 54 allopurinol 54 #mg BID [003] 54 sd = 54 nonfasting triglycerides 54 bad cholesterol LDL 54 estimated GFR 54 density lipoprotein cholesterol 54 adjunctive ABILIFY 54 urate lowering therapy 54 nicardipine 54 Fasting glucose levels 54 normal ULN 54 CI #.#-#.# [001] 54 ATACAND 54 Fasting plasma glucose 54 resistant hypertension 54 polyp recurrence 54 EDSS score 54 mmHg p = 54 elevated uric acid 54 nonobese 54 X ULN 54 virological failure 54 serum PSA 54 elevated hsCRP 54 RLAI 54 abacavir lamivudine 54 leukopenia 54 severe hypoglycemia 54 iPTH 54 serum HBV DNA 54 MetS 54 mg qd 54 serum phosphorous 54 serum sodium concentration 54 mg BID dose 54 lopinavir r 54 triglyceride concentrations 54 Index CDAI score 54 A1Cs 54 low dose Iluvien 54 NovoLog ® Mix 53 NATRECOR R 53 serum cholesterol 53 reinfarction 53 comparator arm 53 plasma leptin 53 euthyroid 53 NSTE ACS 53 elevated serum creatinine 53 gastric pH 53 oral allopurinol 53 highest quintile 53 mg ustekinumab 53 -#.# log# 53 triglyceride 53 lipid levels 53 salmeterol fluticasone propionate 53 sinus rhythm 53 #OHD levels 53 aged ≥ 53 PREZISTA ritonavir 53 + PH# 53 serum triglyceride levels 53 total cholesterol triglycerides 53 lipid lowering medications 53 -#.# ± [001] 53 ejection fractions 53 elevated triglycerides 53 systolic dysfunction 53 #mg/kg [002] 53 irbesartan 53 mEq 53 mg simvastatin 53 mg Lucentis 53 severe exacerbations 53 plasma concentrations 53 mg kg dose 53 symptomatic GERD 53 nonfatal myocardial infarction 53 blood Phe levels 53 biochemical recurrence 53 severe neutropenia 53 log# IU mL 53 IPSS 53 mg orally 53 % CI #.#-#.# [002] 53 serum prostate 53 colorectal adenoma 53 hydroxyvitamin D 53 serum aminotransferase levels 53 thiazide diuretics 53 systolic blood pressures 53 elevated blood glucose 53 estimated glomerular filtration 53 CD4 + cell 53 aminotransferase levels 53 candesartan cilexetil 53 Kaplan Meier analysis 53 PREZISTA r 53 statistically significant p = 53 UACR 53 hypogonadal men 53 hyperglycemia 53 glargine 53 CCyR 53 LDL triglycerides 53 detemir 53 metformin sulphonylurea 53 mg tid 53 #.#/#.# mm Hg [002] 53 fructosamine 53 platelet inhibition 53 hypertensive patients 53 Baseline characteristics 53 mL sec 53 plasma triglycerides 53 #mg [003] 53 tipranavir r 53 thromboembolic events 53 magnesium intake 53 poor metabolizers 53 premenopausal 53 refractory ischemia 53 HBV DNA levels 53 Lucentis monotherapy 53 fasting triglycerides 53 blood Phe 53 leukocyte count 53 venous thrombosis 53 mean baseline A1C 53 SGPT 53 Lp PLA2 53 elevated triglyceride levels 53 undetectable viral 53 EDSS scores 53 OADs 53 HGPIN 53 plasma homocysteine 52 intima media thickness 52 micromoles 52 HCV RNA 52 postprandial blood glucose 52 macroalbuminuria 52 hsCRP 52 β blocker 52 mg Androxal 52 hyperphenylalaninemia HPA due 52 #ug [001] 52 PSADT 52 certolizumab 52 chlorambucil 52 erythrocyte sedimentation rate 52 #.#mmHg 52 cTnT 52 triglyceride TG 52 MMSE score 52 CC genotype 52 HIV RNA 52 atazanavir ritonavir 52 hypophosphatemia 52 oxycodone IR 52 interquartile range 52 kg m² 52 serum leptin 52 pmol liter 52 TAXUS p value 52 ertapenem 52 mcg QD 52 adenoma 52 serum calcium levels 52 D dimer 52 myocardial infarction 52 pg g 52 preintervention 52 serum sodium levels 52 isoflavone intake 52 colorectal neoplasia 52 Severe hypoglycemia 52 rapid virological response 52 subclinical hyperthyroidism 52 oral antidiabetes 52 lipid lowering drugs 52 CDAI 52 albumin excretion rate 52 elevated fasting glucose 52 #.#/#.# mm Hg [003] 52 -#.# ± [002] 52 deciliter 52 mineral density 52 aspirin clopidogrel 52 serum retinol 52 HDL Cholesterol 52 XIENCE V PROMUS Stent 52 LEXIVA r 52 CR nPR 52 periprocedural 52 NNT = 52 lispro alone 52 antibody titer 52 plus GP IIb 52 fasting plasma 52 Calcium intake 52 albumin creatinine ratio 52 #μg [001] 52 HDL cholesterol 52 ARCOXIA 52 fraction LVEF 52 left ventricular systolic 52 transaminase elevations 52 mcg Albuferon 52 log# reduction 52 colorectal polyp 52 hypoglycemic episodes 52 tolvaptan 52 mg RDEA# 52 bone marrow reticulin 52 myocardial infarction MI 52 budesonide pMDI 52 LDL Cholesterol 52 Serum creatinine 52 renal dysfunction 52 serum PTH 52 eplerenone 52 Lantus ® 52 atherogenic dyslipidemia 52 elevated LDL 52 serum CRP 52 fatal myocardial infarction 52 serum ferritin 52 oral hypoglycemic agents 52 hydroxymethyl coenzyme 52 % CI #.#-#.# [004] 52 IELT 52 CD4 counts 52 ALT elevations 52 cerebrovascular events 52 antihypertensive medication 52 infarct size 52 Pred Forte 52 left ventricular dysfunction 52 Acetate Rectal Suppositories 52 residual platelet reactivity 52 chlorthalidone 52 per decilitre 52 timepoint 52 glipizide 52 serum folate 52 tamsulosin 52 transaminase levels 52 mL 52 Crohn Disease Activity 52 aminotransferase elevations greater 52 CI #.#-#.# [002] 52 serum cortisol 52 β blockers 52 MULTAQ 52 blood glucose 52 serum homocysteine 52 renal impairment 52 SHBG levels 52 metformin sulfonylurea 52 atherothrombotic events 52 Elitek 52 μg g 52 coronary revascularization 52 CRESTOR #mg 52 glycoprotein IIb IIIa inhibitors 52 micrograms mcg 52 mild renal insufficiency 52 TC HDL 51 Hemoglobin A1c HbA1c 51 dose colchicine 51 adiponectin concentrations 51 IU ml 51 ug dl 51 tertiles 51 left ventricular hypertrophy 51 mL kg 51 ACTOplus met 51 aminotransferase ALT 51 1c HbA 1c 51 #mg doses [002] 51 p = .# [002] 51 EXJADE 51 coronary stenosis 51 nanograms milliliter 51 inadequate glycemic 51 sustained virologic response 51 acarbose 51 acrylamide intake 51 diuretic chlorthalidone 51 ± SD 51 serum TSH 51 NHANES III 51 per milliliter 51 dietary fiber intake 51 serum ALT 51 5-FU/LV 51 ramipril 51 glomerular filtration 51 uric acid levels 51 lumbar spine bone 51 ± 51 tertile 51 hypercholesterolemia 51 kcal d 51 triglycerides 51 dietary intake 51 bezafibrate 51 DAS# scores 51 atheroma volume 51 AVODART 51 platelet reactivity 51 μg ml 51 retinal thickness 51 paricalcitol 51 nocturnal hypoglycaemia 51 metformin 51 Ishak fibrosis score 51 peak VO2 51 metformin monotherapy 51 triglycerides TG 51 adenomas 51 candesartan 51 IRLS score 51 glycemic control 51 CsA 51 plus dexamethasone 51 APTIVUS r 51 receiving ISENTRESS 51 URTI 51 mm3 51 lipid parameters 51 μg dose 51 plus glycoprotein IIb 51 nondrinkers 51 Unified Parkinson Disease 51 mg calcium 51 laboratory abnormalities 51 μg dl 51 IDDM 51 MACCE 51 hypertensive 51 elevated LDH 51 rosuvastatin 51 anti HBs 51 enoxaparin 51 rs# [002] 51 serum lipid levels 51 folate intake 51 asthma exacerbation 51 thyroid stimulating hormone 51 creatine kinase 51 hours postdose 51 fetuin 51 mg q#h 51 undergoing coronary angiography 51 simvastatin #mg 51 blood glucose concentrations 51 tHcy concentrations 51 idraparinux 51 glyburide 51 serum triglyceride 51 KOMBIGLYZE XR 51 sulfonylurea 51 evaluable 51 thrombotic events 51 sitagliptin 51 peginterferon 51 Index CDAI 51 mild renal impairment 51 nonfatal stroke 51 rimonabant #mg 51 alkaline phosphatase 51 cilostazol 51 serum LDL cholesterol 51 gallstone disease 51 baseline FEV 51 XIENCE V vs. 51 renal insufficiency 51 folic acid takers 51 p = NS 51 renal function 51 -#.# mmol L 51 #mg dose [003] 51 hypoglycemic events 51 antibody titers 51 mcg albinterferon alfa 2b 51 postoperative mortality 51 endometrial thickness 51 folate concentrations 51 cervical intraepithelial neoplasia 51 CD4 cell 51 elevated homocysteine 51 ULORIC 51 calcium intake 51 calcium intakes 51 test OGTT 51 Scale EDSS score 51 complete cytogenetic response 51 cTnI 51 preoperatively 51 diastolic hypertension 51 carotid stenosis 51 stable angina 51 spontaneous bowel movements 51 ezetimibe simvastatin 51 density lipoprotein HDL cholesterol 51 N telopeptide 51 NIHSS score 51 TEAEs 51 PROCTOCORT ® Suppository Hydrocortisone 51 Hemoglobin A1c 51 vitamin D2 51 #mm Hg 51 HBeAg 51 adenoma recurrence 51 CVD mortality 51 glycosylated hemoglobin levels 51 REMICADE monotherapy 51 isolated systolic hypertension 51 % CI #.#-#.# [007] 51 onset diabetes mellitus 51 platelet counts 51 3mg 51 haemorrhagic stroke 51 amoxicillin clavulanate 50 sham injections 50 nondepressed 50 Mg Uk 50 apolipoprotein B 50 posaconazole 50 serum testosterone levels 50 urinary calcium 50 CI = 50 Psoriasis Area 50 NIHSS 50 Left Ventricular Ejection Fraction 50 milliliters mL 50 quetiapine 50 serum transaminases 50 sulphonylurea 50 BMI #-#.# 50 μg doses 50 posttransplant 50 #.#g/day 50 placebo dexamethasone 50 aldosterone antagonist 50 unfractionated heparin UFH 50 overt nephropathy 50 ONGLYZA 50 dose clopidogrel 50 alanine transaminase ALT 50 lamotrigine 50 hyperlipidaemia 50 biphasic insulin aspart 50 LS BMD 50 cGy 50 fluticasone salmeterol 50 EpCAM expression 50 eptifibatide 50 rapid virologic response 50 Expanded Disability Status 50 endoscopic remission 50 revascularization procedures 50 Prehypertension 50 target vessel revascularization 50 neoplasia PIN 50 NNRTI resistance 50 NOLVADEX 50 microalbumin test 50 gestational hypertension 50 HCTZ 50 density lipoprotein cholesterol HDL 50 cystatin C 50 EBRT 50 noncarriers 50 abciximab 50 ‰ ¥ 50 pulmonary exacerbations 50 dysglycemia 50 ALT elevation 50 serum lipid 50 RBC folate 50 impaired glucose tolerance 50 ml min 50 lymphocyte count 50 nonobstructive CAD 50 primary efficacy endpoint 50 metformin hydrochloride 50 C Reactive Protein 50 valproate 50 isoprostane 50 SCr 50 cirrhotic patients 50 abacavir 50 hypertensives 50 lanthanum carbonate 50 tapentadol ER 50 cells mcL 50 hypopneas 50 NATRECOR ® 50 distal colon cancer 50 serum estradiol 50 symptomatic intracerebral hemorrhage 50 PaO 2 50 nonresponders 50 dietary calcium intake 50 lipid lowering agents 50 nonpregnant women 50 adefovir 50 dalteparin 50 kaempferol 50 CIMZIA TM 50 flutamide 50 LPV r 50 Taxus Stent 50 Lantus R 50 serum HCV RNA 50 peginterferon alfa 2b 50 ipsilateral stroke 50 endarterectomy 50 gout flares 50 quetiapine risperidone 50 post prandial glucose 50 posttreatment 50 d dimer 50 detectable HCV RNA 50 pegylated interferon alfa 2b 50 colesevelam HCl 50 pravastatin therapy 50 malignancy HCM 50 p = #.# [003] 50 elevated troponin 50 Engerix B 50 impaired renal 50 ARIXTRA 50 eosinophil count 50 microalbumin 50 fragility fracture 50 nonsignificant difference 50 statin 50 refractory NSCLC 50 GH deficiency 50 methotrexate monotherapy 50 noninferiority 50 severe renal insufficiency 50 left ventricular ejection 50 depressive symptoms 50 drank caffeinated 50 TT genotype 50 experienced virologic failure 50 FOLFOX4 50 QTc 50 lipid profiles 50 tolterodine ER 50 antigen PSA 50 dexamethasone 50 methylmalonic acid 50 blood glucose levels 50 ACR Pedi 50 cardiovascular morbidity 50 ritonavir boosted 50 GnRH agonist 50 protein excretion 50 SELENA SLEDAI score 50 dizziness nausea diarrhea 50 mg dosed 50 Viread Emtriva Sustiva 50 confidence intervals CIs 50 PRADAXA 50 ug ml 50 postmenopausal osteoporotic women 50 metoprolol tartrate 50 morphometric vertebral fractures 50 tPSA 50 Lipitor #mg 50 mcg kg min 50 concomitant antibiotics 50 CLA supplementation 50 recurrent ischemia 50 coronary artery calcification 50 titrated glipizide 50 Median PFS 50 achieved statistical significance 50 BMI ≥ 50 advanced neoplasia 50 adalimumab 50 mcg linaclotide 50 nM 50 thromboembolism 50 alanine transaminase 50 calculated creatinine clearance 50 warfarin 50 hypercholesterolaemia 50 LOVENOX 50 subtrochanteric 50 carotid IMT 50 cTnT levels 50 BPRS PSS 50 pooled comparator 50 HIV uninfected 50 mcg dose 50 HAM D# scores 50 kcal 50 ischemic stroke 50 prior nephrectomy 50 aspirin beta blockers 50 HMG CoA reductase inhibitor 50 diameter stenosis 50 glucose tolerance test 50 Montgomery Åsberg Depression 50 primary percutaneous coronary 50 corticosteroid dose 50 mg p = 50 fosamprenavir 50 urate levels 50 Knodell necroinflammatory score 50 4mg/kg 50 recurrent UTI 50 procalcitonin 50 incontinence episodes 50 Hazard Ratio 50 recurrent atrial fibrillation 50 active comparator 50 placebo fluoxetine 50 Non inferiority 50 ABC/3TC 50 cardiovascular hospitalizations 50 nonvertebral fractures 49 hyperuricemia 49 lung function 49 serum GGT 49 International Prostate Symptom 49 serum albumin 49 SGOT 49 hypercalciuria 49 hemoglobin levels 49 waist circumference 49 quetiapine XR 49 QIDS SR 49 #mg BID [001] 49 ìg 49 postintervention 49 hypercalcemia 49 annualized relapse 49 liver enzymes 49 LDL HDL 49 LDL cholesterol HDL cholesterol

Back to home page